The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. The compounds have been demonstrated as inhibitors of MEK and therefore may be useful in the treatment of hyperproliferative diseases (e.g., cancer and inflammation).
NOVEL MEK INHIBITORS USEFUL IN THE TREATMENT OF DISEASES
申请人:Khire Uday R.
公开号:US20120208859A1
公开(公告)日:2012-08-16
The invention pertains to compound of Formula (I) wherein X, Y, Z, R
1
, R
2
, R
3
, R
4
, A and A′ are as described hereinabove. Formula (I) and (II) compounds can be used in pharmaceutical compositions, useful for the treatment of diseases.
NOVEL MEK INHIBITORS FOR TREATING CARDIOMYOPATHIES AND RELATED CONDITIONS
申请人:Allomek Therapeutics LLC
公开号:US20150250762A1
公开(公告)日:2015-09-10
The invention pertains to compound of Formula (I) wherein X, Y, Z, R1, R2, R3, R4, A, and A′ are described herein. Formula (I) compounds can be used in pharmaceutical compositions, useful for the treatment of disease, in particular cardiovascular conditions and more particularly cardiomyopathies, as well as other related conditions.
MEK inhibitors useful in the treatment of diseases
申请人:Khire Uday R.
公开号:US09034861B2
公开(公告)日:2015-05-19
The invention pertains to compound of Formula (I) wherein X, Y, Z, R1, R2, R3, R4, A and A′ are as described hereinabove. Formula (I) and (II) compounds can be used in pharmaceutical compositions, useful for the treatment of diseases.